Prompted by studies suggesting a role of reference- and/or CNS-PGC-1α in neurodegenerative diseases, we determined whether activation of the RG or CNS promoters modulated the expression of genes implicated in the genetic landscape of these diseases. The gene discussed is PPARGC1A; the disease is neurodegenerative disease.